LeanMASLDNCT07451366
Prevalence of Obesity in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 8 words Show 4 more changesShow less
- Completed without a posted recruiting period
- Primary completion date changed from estimate of Dec 1, 2026 to Jul 1, 2026
- Study sites: 0 to 1
- Study description revised
- Minor Study description shortened, about 17 words
- Study title expanded, about 5 words
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Prevalence of Obesity and Clinical Characteristics of Lean MASLD Patients
Timeframe: 24 month
Sites
1 site in 1 country
- Assiut UniversityAsyut, Egypt